Class information for:
Level 1: THIOSENS//PHARMACOL CELLULAIRE MOL ANTICANC//ALPHANIZOMENON FLOS AQUAE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
32633 136 37.3 86%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
159 3       MENOPAUSE//ISOFLAVONES//TAMOXIFEN 61134
329 2             TAMOXIFEN//ESTROGEN RECEPTOR//AROMATASE INHIBITORS 18133
32633 1                   THIOSENS//PHARMACOL CELLULAIRE MOL ANTICANC//ALPHANIZOMENON FLOS AQUAE 136

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 THIOSENS authKW 449052 1% 100% 2
2 PHARMACOL CELLULAIRE MOL ANTICANC address 299367 1% 67% 2
3 ALPHANIZOMENON FLOS AQUAE authKW 224526 1% 100% 1
4 AMPLIFICATION OF AA METABOLISM authKW 224526 1% 100% 1
5 ANTIESTROGEN DELIVERY authKW 224526 1% 100% 1
6 ATHLET SCI address 224526 1% 100% 1
7 BIOL MOL CELLULAIRE SIGNALISATION address 224526 1% 100% 1
8 BIOL MOL CELLULAIRE SINGALISAT address 224526 1% 100% 1
9 CYTOMETRIC BEAD ANALYSIS authKW 224526 1% 100% 1
10 DOSE DENSE SCHEDULE authKW 224526 1% 100% 1

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 979 44% 0% 60
2 Clinical Neurology 595 29% 0% 40
3 Surgery 69 14% 0% 19
4 Biochemistry & Molecular Biology 62 21% 0% 29
5 Endocrinology & Metabolism 44 8% 0% 11
6 Cell Biology 44 11% 0% 15
7 Pharmacology & Pharmacy 35 12% 0% 16
8 Hematology 12 4% 0% 5
9 Pediatrics 8 4% 0% 5
10 Chemistry, Medicinal 7 3% 0% 4

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PHARMACOL CELLULAIRE MOL ANTICANC 299367 1% 67% 2
2 ATHLET SCI 224526 1% 100% 1
3 BIOL MOL CELLULAIRE SIGNALISATION 224526 1% 100% 1
4 BIOL MOL CELLULAIRE SINGALISAT 224526 1% 100% 1
5 EA3919 224526 1% 100% 1
6 EM10351 224526 1% 100% 1
7 EMI0351 224526 1% 100% 1
8 IFR 186 224526 1% 100% 1
9 IFR186 224526 1% 100% 1
10 INSERM EM10351 224526 1% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF NEURO-ONCOLOGY 12043 13% 0% 17
2 JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY 1962 2% 0% 3
3 PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS 1794 4% 0% 5
4 NEUROSURGERY 1392 7% 0% 9
5 CANCER JOURNAL - FRANCE 922 1% 0% 1
6 PHARMACEUTICAL CHEMISTRY JOURNAL 806 1% 0% 2
7 ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT 602 1% 0% 1
8 JOURNAL OF NEUROSURGERY 595 4% 0% 6
9 CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY 594 1% 0% 1
10 JOURNAL OF BIOLUMINESCENCE AND CHEMILUMINESCENCE 577 1% 0% 1

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 THIOSENS 449052 1% 100% 2 Search THIOSENS Search THIOSENS
2 ALPHANIZOMENON FLOS AQUAE 224526 1% 100% 1 Search ALPHANIZOMENON+FLOS+AQUAE Search ALPHANIZOMENON+FLOS+AQUAE
3 AMPLIFICATION OF AA METABOLISM 224526 1% 100% 1 Search AMPLIFICATION+OF+AA+METABOLISM Search AMPLIFICATION+OF+AA+METABOLISM
4 ANTIESTROGEN DELIVERY 224526 1% 100% 1 Search ANTIESTROGEN+DELIVERY Search ANTIESTROGEN+DELIVERY
5 CYTOMETRIC BEAD ANALYSIS 224526 1% 100% 1 Search CYTOMETRIC+BEAD+ANALYSIS Search CYTOMETRIC+BEAD+ANALYSIS
6 DOSE DENSE SCHEDULE 224526 1% 100% 1 Search DOSE+DENSE+SCHEDULE Search DOSE+DENSE+SCHEDULE
7 GLIOMA TAMOXIFEN 224526 1% 100% 1 Search GLIOMA+TAMOXIFEN Search GLIOMA+TAMOXIFEN
8 LIPID PEROXIDAION 224526 1% 100% 1 Search LIPID+PEROXIDAION Search LIPID+PEROXIDAION
9 LIPOSOMAL FORM 224526 1% 100% 1 Search LIPOSOMAL+FORM Search LIPOSOMAL+FORM
10 PH GRADIENT STEALTH R LIPOSOMES 224526 1% 100% 1 Search PH+GRADIENT+STEALTH+R+LIPOSOMES Search PH+GRADIENT+STEALTH+R+LIPOSOMES

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 DI CRISTOFORI, A , CARRABBA, G , LANFRANCHI, G , MENGHETTI, C , RAMPINI, P , CAROLI, M , (2013) CONTINUOUS TAMOXIFEN AND DOSE-DENSE TEMOZOLOMIDE IN RECURRENT GLIOBLASTOMA.ANTICANCER RESEARCH. VOL. 33. ISSUE 8. P. 3383-3389 13 46% 8
2 PUCHNER, MJA , GIESE, A , LOHMANN, F , CRISTANTE, L , (2004) HIGH-DOSE TAMOXIFEN TREATMENT INCREASES THE INCIDENCE OF MULTIFOCAL TUMOR RECURRENCES IN GLIOBLASTOMA PATIENTS.ANTICANCER RESEARCH. VOL. 24. ISSUE 6. P. 4195 -4203 15 43% 5
3 RAMACHANDRAN, C , KHATIB, Z , PEFKAROU, A , FORT, J , FONSECA, HB , MELNICK, SJ , ESCALON, E , (2004) TAMOXIFEN MODULATION OF ETOPOSIDE CYTOTOXICITY INVOLVES INHIBITION OF PROTEIN KINASE C ACTIVITY AND INSULIN-LIKE GROWTH FACTOR II EXPRESSION IN BRAIN TUMOR CELLS.JOURNAL OF NEURO-ONCOLOGY. VOL. 67. ISSUE 1-2. P. 19-28 16 38% 20
4 COULDWELL, WT , HINTON, DR , SURNOCK, AA , DEGIORGIO, CM , WEINER, LP , APUZZO, MLJ , MASRI, L , LAW, RE , WEISS, MH , (1996) TREATMENT OF RECURRENT MALIGNANT GLIOMAS WITH CHRONIC ORAL HIGH-DOSE TAMOXIFEN.CLINICAL CANCER RESEARCH. VOL. 2. ISSUE 4. P. 619-622 8 80% 92
5 ZHANG, W , HINTON, DR , SURNOCK, AA , COULDWELL, WT , (1996) MALIGNANT GLIOMA SENSITIVITY TO RADIOTHERAPY, HIGH-DOSE TAMOXIFEN, AND HYPERICIN: CORROBORATING CLINICAL RESPONSE IN VITRO: CASE REPORT.NEUROSURGERY. VOL. 38. ISSUE 3. P. 587-590 9 69% 18
6 DA ROCHA, AB , MANS, DRA , BERNARD, EA , RUSCHEL, C , LOGULLO, AF , WETMORE, LA , LEYVA, A , SCHWARTSMANN, G , (1999) TAMOXIFEN INHIBITS PARTICULATE-ASSOCIATED PROTEIN KINASE C ACTIVITY, AND SENSITISES CULTURED HUMAN GLIOBLASTOMA CELLS NOT TO ETOPOSIDE BUT TO GAMMA-RADIATION AND BCNU.EUROPEAN JOURNAL OF CANCER. VOL. 35. ISSUE 5. P. 833-839 11 48% 18
7 PATEL, S , DIBIASE, S , MEISENBERG, B , FLANNERY, T , PATEL, A , DHOPLE, A , CHESTON, S , AMIN, P , (2012) PHASE I CLINICAL TRIAL ASSESSING TEMOZOLOMIDE AND TAMOXIFEN WITH CONCOMITANT RADIOTHERAPY FOR TREATMENT OF HIGH-GRADE GLIOMA.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. VOL. 82. ISSUE 2. P. 739-742 8 42% 13
8 LEVINE, L , (2003) TAMOXIFEN STIMULATES ARACHIDONIC ACID RELEASE FROM RAT LIVER CELLS BY AN ESTROGEN RECEPTOR-INDEPENDENT, NON-GENOMIC MECHANISM.BMC CANCER. VOL. 3. ISSUE . P. 1-6 9 50% 2
9 YOFFE, R , KHAKOO, Y , DUNKEL, IJ , SOUWEIDANE, M , LIS, E , SKLAR, C , (2007) RECURRENT EPENDYMOMA TREATED WITH HIGH-DOSE TAMOXIFEN IN A PERIPUBERTAL FEMALE: IMPACT ON TUMOR AND THE PITUITARY-OVARIAN AXIS.PEDIATRIC BLOOD & CANCER. VOL. 49. ISSUE 5. P. 758-760 7 54% 4
10 PUCHNER, MJA , GIESE, A , ZAPF, S , GREBE, M , WESTPHAL, M , (2001) TAMOXIFEN SENSITIVITY-TESTING OF GLIOBLASTOMAS: COMPARISON OF IN VITRO AND IN VIVO RESULTS.ACTA NEUROCHIRURGICA. VOL. 143. ISSUE 6. P. 563 -573 13 34% 8

Classes with closest relation at Level 1


Rank Class id link
1 5771 ANTIESTROGEN//ANTIESTROGEN BINDING SITES//AEBS
2 25613 UCN 01//7 HYDROXYSTAUROSPORINE//CGP41251
3 1424 TEMOZOLOMIDE//GLIOBLASTOMA//GLIOBLASTOMA MULTIFORME
4 1767 PROTEIN KINASE C//PKC DELTA//CELLULAR CARCINOGENESIS TUMOR PROMOT
5 7620 FULVESTRANT//ENDOCRINE RESISTANCE//FASLODEX
6 9768 HYPERICIN//HYPOCRELLIN A//HYPOCRELLIN
7 19527 ENDOXIFEN//TAMOXIFEN//N DESMETHYLTAMOXIFEN
8 18162 HUMAN MALIGNANT GLIOMAS//MOL EXPT RADIOL//GLIOMA
9 6521 TAMOXIFEN//TOREMIFENE//ANTIESTROGEN
10 27711 PHENYLACETATE//ANTINEOPLASTON AS2 1//PHENYLBUTYRATE

Go to start page